Search for: "DREAMWORKS PRODUCTIONS, INC., a California corporation" Results 1 - 7 of 7
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Oct 2010, 12:27 pm by Mark Litwak
§ 101 et seq. as well as common law breach of contract claims against Defendants Steven Spielberg; DW Studios, LLC; Paramount Pictures Corporation; Viacom, Inc.; NBC Universal, Inc.; Universal Pictures Company, Inc.; Universal City Studios, LLP; United International Pictures, B.V.; and Does 1-10,[1] alleging that the motion picture Disturbia — a film produced by Spielberg, owner of DW Studios, LLC, which is in turn a wholly-owned subsidiary of Paramount… [read post]
28 Mar 2008, 6:00 am
: (Patent Docs),US: Alnylam CEO forecasts ‘perfect storm’ for biomedical patents: (Patent Docs),US: Human Genome launches patent suit against Genentech over type of protein used to detect tumours: (IP Law360)Pharma & Biotech - ProductsCaduet (Atorvastatin/Amlodipine) – US: Pfizer sues Ranbaxy to block generic Caduet until 2016: (IP Law360),Dovonex (Calcipotriol) – Chancery Division EWHC grants interim injunction prohibiting Sandoz from distributing… [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]